» Articles » PMID: 27138766

MicroRNAs As Potential Targets for Treatment of Osteoclast-Related Diseases

Overview
Specialty Pharmacology
Date 2016 May 4
PMID 27138766
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Understanding the roles of miRNAs in osteoclasts has great potential in the diagnosis and treatment of osteolytic diseases.

Objective: The purpose of this paper was to describe the current knowledge of miRNA biogenesis and summarize recent work on the roles of miRNAs in osteoclasts.

Results: There is accumulating evidence to indicate that miRNAs constitute a novel and efficient mechanism for the regulation of gene expression.

Conclusion: Untangling the role that miRNAs play in osteoclastogenesis will illuminate new strategies and specific drug targets for the treatment of osteolytic diseases. Many questions remain, but an in-depth comprehension of the network and kinetics of miRNAs expression, and their connection with cognate genes will not be trivial, but fruitful.

Citing Articles

The DLEU2-miR-15a-16-1 Cluster Is a Determinant of Bone Microarchitecture and Strength in Postmenopausal Women and Mice.

Reppe S, Reseland J, Prijatelj V, Prediger M, Nogueira L, Utheim T Int J Mol Sci. 2024; 25(23).

PMID: 39684435 PMC: 11641114. DOI: 10.3390/ijms252312724.


Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis.

Ma T, Zhu P, Ke Z, Chen J, Hu Y, Xie J Front Endocrinol (Lausanne). 2022; 13:891313.

PMID: 35909545 PMC: 9329542. DOI: 10.3389/fendo.2022.891313.